Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lazertinib 160mg in EGFR T790M NSCLC clinical trial (NCT05701384). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the 160mg dose of lazertinib compare to the standard 240mg dose?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lazertinib 160mg in EGFR T790M NSCLC clinical trial (NCT05701384). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from lazertinib?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lazertinib 160mg in EGFR T790M NSCLC clinical trial (NCT05701384). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits and tests during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lazertinib 160mg in EGFR T790M NSCLC clinical trial (NCT05701384). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lazertinib 160mg in EGFR T790M NSCLC clinical trial (NCT05701384). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lazertinib 160mg in EGFR T790M NSCLC clinical trial (NCT05701384). Contact the study team or your healthcare provider for specific answers.

What this study is about